+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada Defibrillators Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Canada
  • Orion Market Research Private Limited
  • ID: 4969046
UP TO OFF until Dec 31st 2022
Canada has considerable market of defibrillation products due to huge number of heart patients suffering from lingering heart diseases such as CVD, CHD, stroke, hypertension and other heart diseases. Canada contributes significantly to the defibrillator market due to huge investment in healthcare and adoption of innovative technologies in the healthcare domain. According to Canadian Institute of Health Research, more than 1.6 million Canadians are suffering from heart disease.

According to the Heart and Stroke Foundation of Canada, as many as 45,000 Canadians experience a sudden cardiac arrest each year. Early access to cardiopulmonary resuscitation (CPR) and defibrillation (1 to 3 minutes after cardiac arrest) is vital. These actions may increase the chance of survival by 75% or more. Implantation of defibrillators is comparatively cheaper in Canada as compared to the US. The cost of implantation of defibrillator in Canada is around 40%-50% lower than the U. S. Canada has favorable government policies and regulations, which enables it to reduce the cost of surgeries and hospital stay. Every Canadian has a health card issued by Provincial Ministry of Health to avail the benefits of healthcare program. It is estimated that around 70% of Canadian healthcare cost is paid or reimbursed by the Canadian Government.

Also, Canada took various national initiatives for AEDs installation by promoting its access in the region. The goal of the initiative was to ensure that every area in Canada is equipped with AEDs to support training for attendants in using them. A priority of this initiative was to protect the health and safety of Canadians while encouraging physical activities. Risk for cardiac arrest occurs due to intense physical activity, especially in people with underlying cardiovascular disease risk factors such as high blood pressure. According to the Heart and Stroke Foundation Access to early CPR and defibrillation could potentially save the lives of thousands of Canadian adults and children each year. This initiative is applied to all private, public, rural and remote recreational areas, and complemented provincial, territorial and municipal efforts to make AEDs more widely available in as many high-traffic public locations as possible across Canada.

Research Methodology

The market study of the Canada Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Canada Defibrillators Market Research and Analysis by Type
2. Canada Defibrillators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the Canada Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Canada Defibrillators market.
  • Insights about market determinants which are stimulating the Canada Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Canada Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Canada Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Biotronik SE & Co. KG
6.3. Cintas Corp.
6.4. General Electric Co.
6.5. Koninklijke Philips N.V.
6.6. LivaNova PLC
6.7. Medtronic PLC
6.8. Mindray Medical International Co. Ltd.
6.9. Nihon Kohden Corp.
6.10. Stryker Corp.
6.11. ZOLL Medical Corp. (an Asahi Kasei Group company)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cintas Corp.
  • General Electric Co.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Mindray Medical International Co. Ltd.
  • Nihon Kohden Corp.
  • Stryker Corp.
  • ZOLL Medical Corp. (an Asahi Kasei Group company)